STAB (Statera BioPharma) Accumulated Depreciation: $0.00 Mil (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Statera BioPharma Accumulated Depreciation?

Statera BioPharma STAB Accumulated Depreciation is $0.00 Mil as of Sep. 2022.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Statera BioPharma's annual accumulated depreciation increased from Dec. 2019 ($0.00 Mil) to Dec. 2020 ($-0.00 Mil) and increased from Dec. 2020 ($-0.00 Mil) to Dec. 2021 ($-0.03 Mil).

Statera BioPharma Accumulated Depreciation Related Terms

Statera BioPharma Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Accumulated Depreciation Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Accumulated Depreciation
0.00 -0.00 -0.03

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.04 -0.03 0.00 0.00 0.00

Statera BioPharma Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $0.00 Mil mean?
Statera BioPharma (STAB) has a Accumulated Depreciation of $0.00 Mil as of Sep. 2022. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Statera BioPharma and its competitors.
Is Statera BioPharma's Accumulated Depreciation too high?
Statera BioPharma's current Accumulated Depreciation is $0.00 Mil.
How does Statera BioPharma's Accumulated Depreciation compare to NRBO and PALI?
Statera BioPharma's Accumulated Depreciation of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Statera BioPharma and its competitors. Statera BioPharma's current Accumulated Depreciation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (STAB) has a current Accumulated Depreciation of $0.00 Mil. The current Accumulated Depreciation is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Statera BioPharma (STAB), the current Accumulated Depreciation is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.